Oleic acid and derivatives affect human endothelial cell mitochondrial function and vasoactive mediator production.


Journal

Lipids in health and disease
ISSN: 1476-511X
Titre abrégé: Lipids Health Dis
Pays: England
ID NLM: 101147696

Informations de publication

Date de publication:
06 Jun 2020
Historique:
received: 21 11 2019
accepted: 21 05 2020
entrez: 8 6 2020
pubmed: 9 6 2020
medline: 10 4 2021
Statut: epublish

Résumé

Inhalation of common air pollutants such as diesel and biodiesel combustion products can induce vascular changes in humans which may contribute to increased mortality and morbidity associated with fine particulate matter exposures. Diesel, biodiesel, and other combustion byproducts contain fatty acid components capable of entering the body through particulate matter inhalation. Fatty acids can also be endogenously released into circulation following a systemic stress response to some inhaled pollutants such as ozone. When in the circulation, bioactive fatty acids may interact with cells lining the blood vessels, potentially inducing endothelial dysfunction. To examine whether fatty acids could potentially be involved in human vascular responses to air pollutants, we determined the effects of fatty acids and derivatives on important vascular cell functions. Human umbilical vein endothelial cells (HUVEC) were exposed in vitro to oleic acid (OA) or OA metabolites for 4-48 h. Cytotoxicity, vasodilator production (by ELISA measurement), mitochondrial function (using Sea Horse assays), and iron metabolism (inferred by ICP-OES measurements) were examined, with standard statistical testing (ANOVA, t-tests) employed. Dose-dependent cytotoxicity was noted at 24 h, with 12-hydroxy OA more potent than OA. Mitochondrial stress testing showed that 12-hydroxy OA and OA induce mitochondrial dysfunction. Analysis of soluble mediator release from HUVEC showed a dose-dependent increase in prostaglandin F Together, these data demonstrate that FA may be capable of inducing cytotoxic effects and altering expression of mediators of vascular function following inhalation exposure, and may be implicated in air pollutant-induced deaths and hospitalizations. (267 of max 350 words).

Sections du résumé

BACKGROUND BACKGROUND
Inhalation of common air pollutants such as diesel and biodiesel combustion products can induce vascular changes in humans which may contribute to increased mortality and morbidity associated with fine particulate matter exposures. Diesel, biodiesel, and other combustion byproducts contain fatty acid components capable of entering the body through particulate matter inhalation. Fatty acids can also be endogenously released into circulation following a systemic stress response to some inhaled pollutants such as ozone. When in the circulation, bioactive fatty acids may interact with cells lining the blood vessels, potentially inducing endothelial dysfunction. To examine whether fatty acids could potentially be involved in human vascular responses to air pollutants, we determined the effects of fatty acids and derivatives on important vascular cell functions.
METHODS METHODS
Human umbilical vein endothelial cells (HUVEC) were exposed in vitro to oleic acid (OA) or OA metabolites for 4-48 h. Cytotoxicity, vasodilator production (by ELISA measurement), mitochondrial function (using Sea Horse assays), and iron metabolism (inferred by ICP-OES measurements) were examined, with standard statistical testing (ANOVA, t-tests) employed.
RESULTS RESULTS
Dose-dependent cytotoxicity was noted at 24 h, with 12-hydroxy OA more potent than OA. Mitochondrial stress testing showed that 12-hydroxy OA and OA induce mitochondrial dysfunction. Analysis of soluble mediator release from HUVEC showed a dose-dependent increase in prostaglandin F
CONCLUSIONS CONCLUSIONS
Together, these data demonstrate that FA may be capable of inducing cytotoxic effects and altering expression of mediators of vascular function following inhalation exposure, and may be implicated in air pollutant-induced deaths and hospitalizations. (267 of max 350 words).

Identifiants

pubmed: 32505182
doi: 10.1186/s12944-020-01296-6
pii: 10.1186/s12944-020-01296-6
pmc: PMC7275404
doi:

Substances chimiques

Air Pollutants 0
Ricinoleic Acids 0
Intercellular Adhesion Molecule-1 126547-89-5
Oleic Acid 2UMI9U37CP
Dinoprost B7IN85G1HY
Iron E1UOL152H7
Cyclooxygenase 2 EC 1.14.99.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

128

Subventions

Organisme : U.S. Environmental Protection Agency
ID : CR-83578501
Organisme : U.S. Environmental Protection Agency
ID : 92429801

Références

J Lipid Res. 2010 Jan;51(1):120-31
pubmed: 19625735
Am J Respir Crit Care Med. 2007 Aug 15;176(4):395-400
pubmed: 17446340
Indian J Biochem Biophys. 1993 Aug;30(4):224-8
pubmed: 8276425
J Physiol Pharmacol. 2005 Dec;56(4):611-25
pubmed: 16391418
Clin Chim Acta. 2008 Jun;392(1-2):11-6
pubmed: 18328818
Toxicol In Vitro. 2011 Dec;25(8):2140-6
pubmed: 21723937
Diabetes. 2000 Jul;49(7):1231-8
pubmed: 10909983
Am J Pathol. 1991 Dec;139(6):1425-34
pubmed: 1750512
Am J Respir Crit Care Med. 2016 Jun 15;193(12):1382-91
pubmed: 26745856
Curr Med Chem. 2006;13(14):1655-65
pubmed: 16787211
Hypertension. 1995 Nov;26(5):764-70
pubmed: 7591016
Biochim Biophys Acta. 1989 Jun 28;1003(3):232-7
pubmed: 2742859
Circ Res. 2013 Apr 12;112(8):1171-88
pubmed: 23580773
Front Physiol. 2014 May 06;5:175
pubmed: 24834056
J Air Waste Manag Assoc. 2006 Jun;56(6):709-42
pubmed: 16805397
Environ Health Perspect. 2007 Apr;115(4):535-40
pubmed: 17450221
Clin Chem Lab Med. 2013 Apr;51(4):799-810
pubmed: 23006900
Toxicol Appl Pharmacol. 2015 Jul 15;286(2):65-79
pubmed: 25838073
Toxicol Appl Pharmacol. 2018 Mar 01;342:99-107
pubmed: 29407367
J Biol Chem. 2001 Apr 13;276(15):12035-40
pubmed: 11134037
JPEN J Parenter Enteral Nutr. 2015 Sep;39(1 Suppl):18S-32S
pubmed: 26177664
Free Radic Biol Med. 2005 Nov 15;39(10):1385-98
pubmed: 16257648
Circ Res. 1961 May;9:631-8
pubmed: 13752687
Environ Health Perspect. 2001 Aug;109 Suppl 4:483-6
pubmed: 11544151
Int J Hyg Environ Health. 2011 Mar;214(2):138-44
pubmed: 21095158
J Clin Invest. 1989 Nov;84(5):1609-19
pubmed: 2553777
Free Radic Biol Med. 2005 Nov 15;39(10):1305-9
pubmed: 16257639
Biochim Biophys Acta. 2002 Sep 10;1555(1-3):160-5
pubmed: 12206909
Atherosclerosis. 2005 Jun;180(2):245-54
pubmed: 15910849
Eur J Pharm Sci. 2008 Dec 18;35(5):397-403
pubmed: 18812221
Nitric Oxide. 2002 Dec;7(4):254-61
pubmed: 12446174
J Clin Invest. 1997 Sep 1;100(5):1230-9
pubmed: 9276741
Proc Natl Acad Sci U S A. 2009 May 12;106(19):7985-90
pubmed: 19416858
Inhal Toxicol. 2002 Oct;14(10):1069-86
pubmed: 12396411
Free Radic Biol Med. 2006 Dec 1;41(11):1662-9
pubmed: 17145554
J Toxicol Environ Health B Crit Rev. 2012;15(1):1-21
pubmed: 22202227
J Toxicol Environ Health A. 2019;82(5):383-386
pubmed: 30983526
Am J Physiol Cell Physiol. 2003 Jan;284(1):C24-32
pubmed: 12388087
Chem Res Toxicol. 2015 Nov 16;28(11):2104-11
pubmed: 26462088
J Biol Chem. 2009 Jan 23;284(4):2176-86
pubmed: 19033436
Atherosclerosis. 1991 Jan;86(1):85-90
pubmed: 2064637
FEBS Lett. 2001 Feb 23;491(1-2):45-9
pubmed: 11226416
Metabolism. 2005 Dec;54(12):1600-9
pubmed: 16311092
Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5379-84
pubmed: 16565215
Toxicol Sci. 2017 Aug 1;158(2):454-464
pubmed: 28541489
Clin Chem Lab Med. 2008;46(4):429-34
pubmed: 18605928

Auteurs

Virginia L Bass (VL)

Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, 27514, North Carolina, USA.
Current Affiliation: RAI Services Company, Winston-Salem, NC, USA.

Joleen M Soukup (JM)

Clinical Research Branch, Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, ORD, U.S. Environmental Protection Agency, 104 Mason Farm Rd, Chapel Hill, NC, 27514, USA.

Andrew J Ghio (AJ)

Clinical Research Branch, Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, ORD, U.S. Environmental Protection Agency, 104 Mason Farm Rd, Chapel Hill, NC, 27514, USA.

Michael C Madden (MC)

Clinical Research Branch, Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, ORD, U.S. Environmental Protection Agency, 104 Mason Farm Rd, Chapel Hill, NC, 27514, USA. madden.michael@epa.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH